MUC1 upregulates programmed death-ligand 1 (PD-L1) expression in non-small cell lung cancer (NSCLC), and this is reversed by the MUC1 cytoplasmic domain inhibitor GO-203. Here, CD274 is linked to non-small cell lung carcinoma.